✦ LIBER ✦

6500 ORAL Second Interim Results of the GIDEON (Global Investigation of Therapeutic DEcisions in HCC and of Its Treatment With SorafeNib) Study – Barcelona-Clinic Liver Cancer (BCLC) Stage Subgroup Analysis

✍ Scribed by Lencioni, R.; Venook, A.P.; Marrero, J.A.; Kudo, M.; Ye, S.L.; Nakajima, K.; Cihon, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

81 GIDEON (GLOBAL INVESTIGATION OF THERA

✍ J.-P. Bronowicki; R. Lencioni; A. Venook; J. Marrero; M. Kudo; S.-L. Ye; K. Naka 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

109 GIDEON (GLOBAL INVESTIGATION OF THER

✍ J.-P. Bronowicki; S.-L. Ye; M. Kudo; J. Marrero; L. Dagher; J. Furuse; J.F. Gesc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 120 KB

First interim analysis of the GIDEON (Gl

✍ R. Lencioni; M. Kudo; S.-L. Ye; J.-P. Bronowicki; X.-P. Chen; L. Dagher; J. Furu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Abstract No. 241: Worldwide trends in lo

✍ Geschwind, J.F.; Lencioni, R.; Marrero, J.; Venook, A.; Ye, S.; Nakajima, K.; Ku 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Abstract No. 196: Worldwide trends in lo

✍ Geschwind, J.F.; Lencioni, R.; Marrero, J.; Venook, A.; Ye, S.; Nakajima, K.; Ku 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB